Viking Therapeutics Ownership | Who Owns Viking Therapeutics?

Overview ForecastFinancials Chart Transcripts

Viking Therapeutics Ownership Summary

Viking Therapeutics is owned by 37.84% institutional investors, 2.15% insiders, and 60.01% retail investors. Vanguard group is the largest institutional shareholder, holding 8.89% of VKTX shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 4.61% of its assets in Viking Therapeutics shares.

VKTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Viking Therapeutics	37.84%	2.15%	60.01%
Sector	Healthcare Stocks	232.01%	10.74%	-142.75%
Industry	Biotech Stocks	381.47%	10.55%	-292.02%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	9.98M	8.89%	$351.25M
Blackrock funding, inc. /de	6.61M	5.87%	$232.61M
Blackrock	6.03M	5.82%	$319.45M
Fmr	5.79M	5.16%	$152.16M
State street	4.45M	3.90%	$156.39B
Morgan stanley	3.08M	2.70%	$108.22M
Ameriprise financial	2.09M	1.87%	$55.00B
Two sigma investments, lp	2.09M	1.86%	$54.81M
Geode capital management	1.99M	1.77%	$70.18M
Two sigma advisers, lp	1.56M	1.39%	$40.87M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Profit investment management	18.00K	2.56%	$633.07K
First washington	266.84K	1.88%	$7.01M
Kintayl capital lp	100.19K	1.62%	$2.63M
Toms capital investment management lp	763.60K	1.52%	$40.48M
Diadema partners lp	193.69K	1.30%	$5.09M
Quantum private wealth	105.33K	1.08%	$3.71M
Maso capital partners	25.00K	1.08%	$657.00K
Blackbarn capital partners lp	500.00K	0.94%	$13.14M
Lewis asset management	61.89K	0.89%	$2.18M
Tang capital management	870.00K	0.88%	$22.86M

Top Buyers

Holder	Shares	% Assets	Change
Norges bank	1.28M	0.01%	1.28M
Blackrock funding, inc. /de	6.61M	0.00%	1.02M
Balyasny asset management	860.45K	0.05%	860.45K
Bnp paribas arbitrage, snc	992.70K	0.02%	836.39K
Two sigma investments, lp	2.09M	0.08%	771.70K

Top Sellers

Holder	Shares	% Assets	Change
Fmr	5.79M	0.01%	-4.03M
Avoro capital advisors	-	-	-3.59M
Blackrock	6.03M	0.01%	-2.25M
Jpmorgan chase	546.83K	0.00%	-2.03M
Massachusetts financial services co /ma/	-	-	-1.36M

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	1.28M	0.01%	1.28M	$51.46M
Toms capital investment management lp	763.60K	1.52%	763.60K	$40.48M
Baker bros. advisors lp	366.08K	0.07%	366.08K	$9.62M
Bridgewater associates, lp	123.49K	0.01%	123.49K	$3.25M
Soros fund management	90.00K	0.04%	90.00K	$3.17M

Sold Out

Holder	Change
True wealth design	-1.00
Twin peaks wealth advisors	-2.00
Mather group, llc.	-3.00
Concord wealth partners	-5.00
Total investment management	-8.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	295	-26.62%	42,499,369	-40.36%	37	0.94%	135	-31.82%	94	-12.15%
Sep 30, 2025	387	-6.52%	69,883,492	-2.34%	62	1.53%	194	-15.28%	101	-5.61%
Jun 30, 2025	413	1.72%	76,058,977	0.09%	67	1.48%	224	-0.44%	108	3.85%
Mar 31, 2025	402	-10.67%	76,083,022	-7.14%	67	1.24%	220	-5.98%	105	-16.67%
Dec 31, 2024	414	-10.78%	75,828,361	-8.31%	68	1.23%	216	-21.17%	114	6.54%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl O	5.10M	4.61%	70.32K
Vanguard US Total Market Shares ETF	3.32M	2.96%	2.50K
Vanguard Total Stock Mkt Idx Inv	3.39M	2.93%	9.66K
State Street® SPDR® S&P® Biotech ETF	2.67M	2.31%	-14.31K
Vanguard Small Cap Index	2.43M	2.10%	350.00
SPDR® S&P Biotech ETF	1.92M	1.71%	4.29K
Vanguard Small Cap Growth Index Inv	1.35M	1.17%	-20.06K
Jupiter Merian Glb Eq AbsRet I USD Acc	1.30M	1.12%	1.30M
Vanguard Institutional Extnd Mkt Idx Tr	1.22M	1.06%	4.99K
Fidelity Growth Compy Commingled Pl S	1.14M	1.01%	-454.62K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 10, 2026	Aubuchon Neil William	Chief Commercial Officer	Buy	$149.91K
Jan 05, 2026	ZANTE GREG	Chief Financial Officer	Sell	$464.02K
Jan 05, 2026	ZANTE GREG	Chief Financial Officer	Sell	$352.63K
Jan 05, 2026	ZANTE GREG	Chief Financial Officer	Sell	$1.03M
Jan 05, 2026	ZANTE GREG	Chief Financial Officer	Sell	$48.13K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	1	13
2025 Q4	-	4
2025 Q3	-	3
2025 Q2	-	-
2025 Q1	1	6

VKTX Ownership FAQ

Who Owns Viking Therapeutics?

Viking Therapeutics shareholders are primarily institutional investors at 37.84%, followed by 2.15% insiders and 60.01% retail investors. The average institutional ownership in Viking Therapeutics's industry, Biotech Stocks , is 381.47%, which Viking Therapeutics falls below.

Who owns the most shares of Viking Therapeutics?

Viking Therapeutics’s largest shareholders are Vanguard group (9.98M shares, 8.89%), Blackrock funding, inc. /de (6.61M shares, 5.87%), and Blackrock (6.03M shares, 5.82%). Together, they hold 20.58% of Viking Therapeutics’s total shares outstanding.

Does Blackrock own Viking Therapeutics?

Yes, BlackRock owns 5.82% of Viking Therapeutics, totaling 6.03M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 319.45M$. In the last quarter, BlackRock decreased its holdings by -2.248M shares, a -27.17% change.

Who is Viking Therapeutics’s biggest shareholder by percentage of total assets invested?

Profit investment management is Viking Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.56% of its assets in 18K Viking Therapeutics shares, valued at 633.06K$.

Who is the top mutual fund holder of Viking Therapeutics shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of Viking Therapeutics shares, with 4.61% of its total shares outstanding invested in 5.1M Viking Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools